Affiliation:
1. Ryzhikh National Medical Research Center of Coloproctology
Abstract
AIM: to determine the diagnostic efficiency of magnetic resonance enterocolonography using inflammation indices (CDMI, MEGS) in assessing activity of the inflammatory process in the colon and small intestine in Crohn's disease.PATIENTS AND METHODS: the study included 42 patients with Crohn's disease (age ranged from 19 to 47 years). All patients underwent magnetic resonance enterocolonography (MRE) with intravenous contrast and diffusion-weighted images. According to the results of MRE, were determined MR indices of inflammation activity in the small and large intestine - CDMI and MEGS. The MR inflammatory activity indices CDMI and MEGS were compared with the endoscopic inflammatory activity index SES-CD.RESULTS: the MR inflammation activity index CDMI did not show a statistically significant diagnostic efficiency (p>0.05). The MR inflammation activity index MEGS showed a statistically significant diagnostic efficiency (p<0.0001). According to the nomogram, the MR inflammation activity index MEGS demonstrated a high predictive ability to determine the true activity of the inflammatory process in the small and large intestine. Correlation demonstrated direct strong relationship between the quantitative values of the MEGS inflammation indices and the endoscopic inflammation index (SES-CD) (r=0.843, p<0.0001).CONCLUSION: magnetic resonance enterocolonography using the MEGS activity index has a high diagnostic efficiency in assessing the activity of the inflammatory process in the small and large intestine in Crohn's disease. The MR inflammation activity index CDMI did not show statistically significant diagnostic efficacy. The results of the study should be considered preliminary and require further study of the possibilities of these indices of inflammation activity in a larger sample of patients.
Publisher
Russian Association of Coloproctology
Subject
Gastroenterology,Oncology,Surgery
Reference24 articles.
1. Ivashkin V.T., Shelygin Yu.A., Khalif I.L. et al. Clinical recommendations of the Russian Gastroenterological Association and the Association of Coloproctologists of Russia on the diagnosis and treatment of Crohn's disease. Koloproktologia. 2017;2(60):7-29 (in Russ.).
2. Khalif I.L., Vardanyan A.V., Shapina M.V. Antirecurrent treatment of Crohn's disease in the postoperative period. Literature review. Koloproktologia. 2017;3(61):63-70 (in Russ.).
3. Vardanyan A.V., Toboeva M.Kh., Zarodnyuk I.V. et al. Stricturoplasty as an organ-preserving technique in patients with Crohn’s disease of the small intestine (clinical case). Koloproktologia. 2019;3(69):77-83 (in Russ.). https://doi.org/10.33878/2073-7556-2019-18-3-77-83
4. Peyrin-BirouletL, Sandborn W, Sands BE, et al. Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target. Am J Gastroenterol. 2015; 110: 1324–1338. DOI: 10.1038/ajg.2015.233.
5. Khanna R, Jairath V and Feagan BG. The evolution of treatment paradigms in crohn’s disease: beyond better drugs. Gastroenterol Clin North Am. 2017;46:661–677. DOI: 10.1016/j.gtc.2017.05.010.